Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

IL-10 promoter polymorphisms influence disease severity and course in psoriasis

Kingo, K., Kõks, S., Silm, H. and Vasar, E. (2003) IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes & Immunity, 4 (6). pp. 455-457.

Link to Published Version:
*Subscription may be required


We analyzed three single-nucleotide polymorphisms (SNPs) at the interleukin-10 (IL-10) 5′ flanking region (positions −1082 A/G, −819 C/T and −592 C/A) in an association case–control study involving 248 patients with plaque type of psoriasis and 148 unrelated healthy volunteers using ARMS (amplification refractory mutation system)-PCR (Polymerase Chain Reaction) method. No difference was found in the frequencies of haplotype distribution between healthy controls and patients with psoriasis. There were no significant differences in the IL-10 haplotype distribution depending on the age of onset and family history of psoriasis. However, the results of our study demonstrate that the IL-10 haplotype has a role in determining severity and course of plaque type of psoriasis. IL-10 ACC haplotype (P<0.05) is likely to be defining lower activity of disease (PASI≤20; extent≤10%) and ATA haplotype is likely to be associated with persistent eruption (P<0.01). As ACC haplotype is suggested to be associated with high IL-10 secretion and ATA is related to low IL-10 secretion, potential differences in the IL-10 secretion levels might contribute the differences in the clinical course of psoriasis.

Item Type: Journal Article
Publisher: Springer Nature
Copyright: © 2019 Springer Nature Limited
Item Control Page Item Control Page